Home Public Health Tags

Public Health

Health Policy 101 is a comprehensive guide covering fundamental aspects of U.S. health policy and programs, including Medicare, Medicaid, the Affordable Care Act, employer-sponsored insurance, the uninsured population, health care costs and affordability, women's health issues, and health care politics. The Public Health chapter examines how public health is governed and delivered in the United States. It includes explanations of key public health frameworks, services, capabilities and characteristics, how the public health system works in state, local and territorial governments, and public health funding, workforce, and communication challenges in an era of declining trust.

View the Chapter →

View the Latest: Public Health

Filter

List Grid

131 - 140 of 280 Results

  • KFF Analysis Finds That Firearms Were Involved in 79% of Homicides and 55% of Suicide Deaths in 2022

    News Release

    A new KFF analysis finds that firearms are involved in the majority of all homicides and suicides in the U.S., playing a role in 79% of homicides and 55% of suicide deaths in 2022, the most recent data available.The analysis, based on data from the federal Centers for Disease Control and Prevention, also shows that firearm deaths increased sharply over the decade, from 33,563 deaths in 2012 to 48,204 deaths in 2022. Looked at another…

  • What the Data Show: Firearms Violence

    Feature

    The U.S. has by far the highest homicide by firearm rate among similarly large and wealthy countries, including among children and teens.

  • Eight to 24 Million Could Lose Medicaid Coverage by May 2024 Due to the End of Pandemic-era Enrollment Protections

    News Release

    A new KFF analysis finds that between 8 and 24 million people across the U.S. could be disenrolled from Medicaid during the unwinding of the program’s continuous enrollment provision. The estimates draw on data collected through KFF’s recent survey of state Medicaid and CHIP officials, conducted with the Georgetown University Center for Children and Families. The survey focused on states’ eligibility and enrollment policies, and their approaches to the unwinding of pandemic-era protections that prevented…

  • What’s Next for Health Policy After the Election?

    Event Date:
    Event

    On Tuesday, November 15, two experts joined series moderator Larry Levitt in a 45-minute discussion looking at what’s ahead for health policy on the Hill, in the Administration, and in the states after the election.

  • Webinar: How Might the Pandemic Affect Health Premiums, Utilization, and Outcomes in 2021 and Beyond?

    Event Date:
    Event

    As the coronavirus pandemic enters its eighth month, we are still facing uncertainty about what the long-term impact of the crisis will be for the health sector, and for patients. However, the extent to which costs grow, and how the burden is distributed across payers, programs, individuals, outcomes, and geography are still very much unknown. On Monday, October 19, KFF held a webinar on the outlook for the U.S. health system in light of the…

  • KFF Health Tracking Poll – October 2020: The Future of the ACA and Biden’s Advantage On Health Care

    Report

    The poll examines the public's views on the Supreme Court case to overturn the Affordable Care Act and its protections for people with pre-existing conditions. Less than a month from the results of the 2020 presidential election, this poll examines the top issues for voters (the economy, the coronavirus pandemic, health care, criminal justice and policing, among others) as well as which candidate, Biden or Trump, they think has the better approach to handle key…

  • Monkeypox Vaccine Roll-out in the U.S. – Are Jurisdictions Requesting All Their Doses?

    Policy Watch

    This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.

  • How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?

    Issue Brief

    This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.